ERYTECH appoints Dr. Iman El-Hariry as Chief Medical Officer Post author:admERY Post published:July 15, 2015 Post category:Newsroom ERYTECH announces the appointment of Iman El-Hariry as Chief Medical Officer, responsible for global medical, clinical and regulatory affairs. You Might Also Like ERYTECH Secures US Patent Directed to Sequential Use of Methioninase & Asparaginase against Solid Tumors November 29, 2021 ERYTECH reports positive Phase 2b data for eryaspase for the treatment of metastatic pancreatic cancer March 27, 2017 ERYTECH provides business update and financial results for the first half of 2015 September 28, 2015
ERYTECH Secures US Patent Directed to Sequential Use of Methioninase & Asparaginase against Solid Tumors November 29, 2021
ERYTECH reports positive Phase 2b data for eryaspase for the treatment of metastatic pancreatic cancer March 27, 2017